Infectious Disease
1950, France — Robert Debré's formal clinical description published in the medical literature
Cat-scratch disease occupied an ambiguous corner of clinical medicine for much of the twentieth century, with physicians debating its cause and nature for decades after the condition was first formally described. Ancient and medieval sources contained no clear references to the disease as a distinct entity, and its identification as a specific clinical syndrome awaited the era of systematic bacteriological investigation. The eventual discovery of its bacterial causative agent in the 1980s and 1990s resolved a long-standing mystery that had frustrated some of the twentieth century's most diligent infectious disease researchers.
Historical Narrative
Early records that might correspond to cat-scratch disease are difficult to identify with certainty, as swollen lymph nodes following animal injury were historically attributed to a wide variety of causes, including wound infection, plague, and humoral imbalance. Medieval European physicians and Islamic scholars such as Ibn Sina documented lymph node swellings—called buboes when associated with infectious contexts—but lacked any framework for distinguishing a cat-related bacterial inoculation from other causes of regional lymphadenopathy. Cats themselves carried complex symbolic and practical roles in premodern societies, and injuries from them were regarded as ordinary occupational hazards of domestic life rather than triggers for a distinct disease process.
The formal clinical recognition of cat-scratch disease as a specific syndrome is attributed to Robert Debré, a prominent French pediatrician, who in 1950 published the first systematic description of the condition. Debré and his colleagues observed a series of patients who developed prolonged regional lymph node enlargement following cat scratches, with no other identifiable infectious cause. Debré named the condition 'maladie des griffes de chat' and distinguished it from other forms of lymphadenopathy, establishing the epidemiological link to feline contact that subsequent investigators would pursue.
Around the same period, American physician F. Hanger and colleagues, as well as researchers including David Daniels, developed a skin test antigen prepared from the pus of affected lymph nodes that produced a delayed hypersensitivity reaction in patients believed to have the disease. This Hanger-Rose test, also called the cat-scratch skin test, became a diagnostic tool used through the mid-twentieth century, even as the causative agent remained unidentified. The antigen was empirically derived, and its use reflected the pragmatic diagnostic strategies employed in the pre-molecular era of infectious disease medicine.
The search for the causative organism proved remarkably protracted. Bacteria, Chlamydia species, and various viral agents were all proposed and investigated across the 1950s through the 1970s, but none gained broad acceptance. The first significant breakthrough came in 1983, when Wear and colleagues at the Armed Forces Institute of Pathology used Warthin-Starry silver staining on biopsy specimens from cat-scratch disease patients and identified small pleomorphic bacilli within the lesions. This finding reinvigorated the search for a specific bacterial pathogen.
In 1988, English and colleagues succeeded in culturing a small gram-negative bacillus from lymph node tissue, initially designated Afipia felis. For a period, Afipia felis was accepted as the likely causative agent. However, subsequent seroepidemiological studies raised doubts, and investigations in the early 1990s redirected attention toward a different organism. Research groups led by David Relman and others, using early molecular phylogenetic methods, examined the 16S ribosomal RNA sequences of organisms isolated from cat-scratch disease patients and identified a distinct bacterium closely related to Rochalimaea species.
By 1992 and 1993, collaborative work involving researchers including Relman, Lucey, Koehler, and others established that Rochalimaea henselae—subsequently reclassified as Bartonella henselae—was the principal causative agent of cat-scratch disease. Epidemiological studies then traced the reservoir of the organism to domestic cats, particularly kittens, and implicated the cat flea as a vector among feline hosts. This resolution, achieved through the application of molecular biological tools unavailable to earlier generations of researchers, closed a chapter of investigation that had spanned more than four decades.
Key Historical Figures
Historical narrative only — this page describes how Cat-scratch disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.